From 1984 until the early 1990s (i.e., prior to the widespread availability of PSA screening), highly statistically significant increasing prostate cancer incidence rates were observed for each five-year age group between the age groups of 60–64 and 80–84. This evidence concerns the gene KLK3 and prostate carcinoma.